Testing effectiveness (Phase 2)Looking for participantsNCT03872661
What this trial is testing
Neoadjuvant IBI308, Bevacizumab, Plus Pemetrexed and Carboplatin Followed by Surgery in Unresectable Stage III NSCLC
Who this might be right for
Lung Cancer Stage III
Sun Yat-sen University 36